The growth in demand for TrialNetworks is largely attributed to sponsors who are using the platform sharing their successes with colleagues managing other trials and with peers at other companies.
Newton, MA (PRWEB) April 24, 2014
TrialNetworks today announced that it ended Q1 2014 with its Clinical Trial Optimization System in use on twice as many active clinical trials as compared to the previous year. The company’s strong momentum from 2013 has continued into the new year as TrialNetworks relocated to a larger corporate headquarters, added experienced industry leaders to its staff, contributed valuable thought leadership and won the Disruptive Technology of the Year award from Partnerships in Clinical Trials.
The growth in demand for TrialNetworks is largely attributed to sponsors who are using the platform sharing their successes (e.g. improved site engagement, increased patient recruitment and retention, streamlined site activation and database lock processes) with colleagues managing other trials and with peers at other companies.
TrialNetworks CEO Eric Silberstein said, “Developing practical technology that solves real problems in an industry as complex as ours is a challenge. Our development team is passionate about taking guidance from our customers, our advisors and our professional services team to enhance our existing apps and create new apps. Our services team is equally passionate about helping sponsors and CROs make optimal use of the TrialNetworks platform. We’re impacting the conduct of clinical trials and I’m happy to see more people in our industry noticing, as reflected in our Q1 results.”
Key highlights from the first quarter of 2014 include:
- Launched Enhanced Apps: Significant new features were added to TrialNetworks Checklist™, Action Items™, Closeout Tracker™ and Directory™ - the latter including exclusive SMART capabilities for self-service site user account provisioning.
- Moved to New Corporate Headquarters: To accommodate growth, TrialNetworks relocated to a new office in a converted mill nestled on the banks of the Charles River outside of Boston with a view of historic Echo Bridge.
- Expanded Senior Management: Additions to the senior management team included global pharmaceutical industry authority Dr. Jorge Guerra joining as Advisory Board Chairman.
- Contributed Thought Leadership: TrialNetworks hosted a case study webinar with Infinity Pharmaceuticals focused on enrollment (watch replay) and was featured in interviews with CenterWatch Weekly and Clinical Leader.
To learn why sponsors and CROs continue to choose TrialNetworks to help them optimize clinical operations, request a demo at http://www.trialnetworks.com.
TrialNetworks provides sponsors and CROs with the award-winning Clinical Trial Optimization System to transform clinical operations quality and efficiency. Customers such as Merck & Co., Biogen Idec and Infinity Pharmaceuticals use this modern and intuitive technology to improve key aspects of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface. Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.